Ixekizumab is prescribed for:
- Moderate-to-severe plaque psoriasis
- Psoriatic arthritis
- Ankylosing spondylitis
- Non-radiographic axial spondyloarthritis
- Dermatologic autoimmune diseases
Generic Name: Ixekizumab
Brand Names: Taltz
Ixekizumab is an IL-17A antagonist biologic for psoriasis and psoriatic arthritis with rapid onset of action.
Ixekizumab is prescribed for:
Common side effects:
Serious side effects:
Ixekizumab is an IL-17A antagonist with high efficacy for psoriasis.
Many patients see significant improvement within 2-4 weeks, faster than some other biologics.
Requires loading doses initially, then maintenance dosing every 4 weeks.
For more information, see MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Ixekizumab? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.